Good to see the discussion building on these threads..very clear...

Good to see the discussion building on these threads..very clear that retail interest is minimal here in Australia, but if you look at the volumes in the OTC markets the last week they have been more than double that of the ASX. 1.2 million on Thursday was for me an inflection point for the stock and the interest for the business. Happy for this to be driven by overseas buying as it will trickle through to Australia in good time.

With regards to valuations, no one can really predict the   Full impact of the farm bill on all the companies involved, but Charlottes Web, CVSI and Elixinol will all be winners in the US.
Where I think Elixinol is ahead of the competition is that they are also positioned globally to maximise the profileration of CBD.
One of the clear indicators is looking at Elixinol’s Google trends. This shows you the global opportunity that they are starting to take advantage of and the focus should be on top line growth and positioning the brand as No 1 in as many markets as possible. The global heat map on link below shows where Elixinol is making significant progress...

https://trends.google.com/trends/explore?q=/g/11bzwmvh9z